747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors
| Autor: | Joal D Beane, Yazan Samhouri, Brent A Hanks, John Hyngstrom, Sarah Weiss, Heidi Gillenwater, Yeonhee Kim, J Randolph Hecht, Bishwa J Ganguly, Hajime Hiraragi, Lucy Gong, Navid Nikoo |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2023-SITC2023.0747 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|